Blastic plasmacytoid dendritic cell neoplasm (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Blastic plasmacytoid dendritic cell neoplasm" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

13doi.org

2^nd place

6semanticscholar.org

11^th place

8^th place

3clinicaltrials.gov

5,225^th place

4,062^nd place

1handle.net

102^nd place

76^th place

1archives-ouvertes.fr

1,031^st place

879^th place

1fda.gov

447^th place

338^th place

1worldcat.org

5^th place

1pharmatimes.com

low place

1immuno-oncologynews.com

low place

archives-ouvertes.fr

hal.archives-ouvertes.fr

Alculumbre S, Raieli S, Hoffmann C, Chelbi R, Danlos FX, Soumelis V (February 2018). "Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association" (PDF). Seminars in Cell & Developmental Biology. 86: 24–35. doi:10.1016/j.semcdb.2018.02.014. PMID 29444460.

clinicaltrials.gov

doi.org

Slater DN (November 2005). "The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants". The British Journal of Dermatology. 153 (5): 874–80. doi:10.1111/j.1365-2133.2005.06905.x. PMID 16225594. S2CID 23625855.
Owczarczyk-Saczonek A, Sokołowska-Wojdyło M, Olszewska B, Malek M, Znajewska-Pander A, Kowalczyk A, Biernat W, Poniatowska-Broniek G, Knopińska-Posłuszny W, Kozielec Z, Nowicki R, Placek W (April 2018). "Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms". Postepy Dermatologii I Alergologii. 35 (2): 128–138. doi:10.5114/ada.2017.72269. PMC 5949541. PMID 29760611.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (May 2016). "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia". Blood. 127 (20): 2391–405. doi:10.1182/blood-2016-03-643544. PMID 27069254.
Sullivan JM, Rizzieri DA (December 2016). "Treatment of blastic plasmacytoid dendritic cell neoplasm". Hematology. American Society of Hematology. Education Program. 2016 (1): 16–23. doi:10.1182/asheducation-2016.1.16. PMC 6142460. PMID 27913457.
Kim MJ, Nasr A, Kabir B, de Nanassy J, Tang K, Menzies-Toman D, Johnston D, El Demellawy D (October 2017). "Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review". Journal of Pediatric Hematology/Oncology. 39 (7): 528–537. doi:10.1097/MPH.0000000000000964. PMID 28906324. S2CID 11799428.
Pemmaraju N (December 2017). "Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond". Current Hematologic Malignancy Reports. 12 (6): 510–512. doi:10.1007/s11899-017-0425-7. PMID 29064022. S2CID 207330989.
Roberts I, Fordham NJ, Rao A, Bain BJ (July 2018). "Neonatal leukaemia". British Journal of Haematology. 182 (2): 170–184. doi:10.1111/bjh.15246. hdl:10044/1/59959. PMID 29806701.
Wang S, Wang X, Liu M, Bai O (April 2018). "Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents". Annals of Hematology. 97 (4): 563–572. doi:10.1007/s00277-018-3259-z. PMID 29455234. S2CID 3627886.
Collin M, Bigley V (May 2018). "Human dendritic cell subsets: an update". Immunology. 154 (1): 3–20. doi:10.1111/imm.12888. PMC 5904714. PMID 29313948.
Alculumbre S, Raieli S, Hoffmann C, Chelbi R, Danlos FX, Soumelis V (February 2018). "Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association" (PDF). Seminars in Cell & Developmental Biology. 86: 24–35. doi:10.1016/j.semcdb.2018.02.014. PMID 29444460.
Sumarriva Lezama L, Chisholm KM, Carneal E, Nagy A, Cascio MJ, Yan J, Chang CC, Cherry A, George TI, Ohgami RS (June 2018). "An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality". Histopathology. 73 (5): 767–776. doi:10.1111/his.13668. PMID 29884995. S2CID 47003308.
Suma S, Sakata-Yanagimoto M, Nguyen TB, Hattori K, Sato T, Noguchi M, Nannya Y, Ogawa S, Watanabe R, Fujimoto M, Nakamura N, Kusakabe M, Nishikii H, Kato T, Chiba S (April 2018). "Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis". International Journal of Hematology. 108 (4): 447–451. doi:10.1007/s12185-018-2461-z. PMID 29705980. S2CID 13993911.
Tandon, a.; Zhang, y.; Sokol, l. (2019). "Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm". Drugs of Today. 55 (12). Portico: 735–742. doi:10.1358/dot.2019.55.12.3058917. ISSN 1699-4019. PMID 31942876.

fda.gov

"FDA approves first treatment for rare blood disease" (Press release). Food and Drug Administration. December 21, 2018.

handle.net

hdl.handle.net

Roberts I, Fordham NJ, Rao A, Bain BJ (July 2018). "Neonatal leukaemia". British Journal of Haematology. 182 (2): 170–184. doi:10.1111/bjh.15246. hdl:10044/1/59959. PMID 29806701.

immuno-oncologynews.com

Melão, Alice (9 November 2017). "FDA Lifts Clinical Hold on Cellectis' UCART123 Trials in AML, BPDCN".

nih.gov

pubmed.ncbi.nlm.nih.gov

Slater DN (November 2005). "The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants". The British Journal of Dermatology. 153 (5): 874–80. doi:10.1111/j.1365-2133.2005.06905.x. PMID 16225594. S2CID 23625855.
Owczarczyk-Saczonek A, Sokołowska-Wojdyło M, Olszewska B, Malek M, Znajewska-Pander A, Kowalczyk A, Biernat W, Poniatowska-Broniek G, Knopińska-Posłuszny W, Kozielec Z, Nowicki R, Placek W (April 2018). "Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms". Postepy Dermatologii I Alergologii. 35 (2): 128–138. doi:10.5114/ada.2017.72269. PMC 5949541. PMID 29760611.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (May 2016). "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia". Blood. 127 (20): 2391–405. doi:10.1182/blood-2016-03-643544. PMID 27069254.
Sullivan JM, Rizzieri DA (December 2016). "Treatment of blastic plasmacytoid dendritic cell neoplasm". Hematology. American Society of Hematology. Education Program. 2016 (1): 16–23. doi:10.1182/asheducation-2016.1.16. PMC 6142460. PMID 27913457.
Kim MJ, Nasr A, Kabir B, de Nanassy J, Tang K, Menzies-Toman D, Johnston D, El Demellawy D (October 2017). "Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review". Journal of Pediatric Hematology/Oncology. 39 (7): 528–537. doi:10.1097/MPH.0000000000000964. PMID 28906324. S2CID 11799428.
Pemmaraju N (December 2017). "Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond". Current Hematologic Malignancy Reports. 12 (6): 510–512. doi:10.1007/s11899-017-0425-7. PMID 29064022. S2CID 207330989.
Roberts I, Fordham NJ, Rao A, Bain BJ (July 2018). "Neonatal leukaemia". British Journal of Haematology. 182 (2): 170–184. doi:10.1111/bjh.15246. hdl:10044/1/59959. PMID 29806701.
Wang S, Wang X, Liu M, Bai O (April 2018). "Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents". Annals of Hematology. 97 (4): 563–572. doi:10.1007/s00277-018-3259-z. PMID 29455234. S2CID 3627886.
Collin M, Bigley V (May 2018). "Human dendritic cell subsets: an update". Immunology. 154 (1): 3–20. doi:10.1111/imm.12888. PMC 5904714. PMID 29313948.
Alculumbre S, Raieli S, Hoffmann C, Chelbi R, Danlos FX, Soumelis V (February 2018). "Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association" (PDF). Seminars in Cell & Developmental Biology. 86: 24–35. doi:10.1016/j.semcdb.2018.02.014. PMID 29444460.
Sumarriva Lezama L, Chisholm KM, Carneal E, Nagy A, Cascio MJ, Yan J, Chang CC, Cherry A, George TI, Ohgami RS (June 2018). "An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality". Histopathology. 73 (5): 767–776. doi:10.1111/his.13668. PMID 29884995. S2CID 47003308.
Suma S, Sakata-Yanagimoto M, Nguyen TB, Hattori K, Sato T, Noguchi M, Nannya Y, Ogawa S, Watanabe R, Fujimoto M, Nakamura N, Kusakabe M, Nishikii H, Kato T, Chiba S (April 2018). "Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis". International Journal of Hematology. 108 (4): 447–451. doi:10.1007/s12185-018-2461-z. PMID 29705980. S2CID 13993911.
Tandon, a.; Zhang, y.; Sokol, l. (2019). "Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm". Drugs of Today. 55 (12). Portico: 735–742. doi:10.1358/dot.2019.55.12.3058917. ISSN 1699-4019. PMID 31942876.

ncbi.nlm.nih.gov

Owczarczyk-Saczonek A, Sokołowska-Wojdyło M, Olszewska B, Malek M, Znajewska-Pander A, Kowalczyk A, Biernat W, Poniatowska-Broniek G, Knopińska-Posłuszny W, Kozielec Z, Nowicki R, Placek W (April 2018). "Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms". Postepy Dermatologii I Alergologii. 35 (2): 128–138. doi:10.5114/ada.2017.72269. PMC 5949541. PMID 29760611.
Sullivan JM, Rizzieri DA (December 2016). "Treatment of blastic plasmacytoid dendritic cell neoplasm". Hematology. American Society of Hematology. Education Program. 2016 (1): 16–23. doi:10.1182/asheducation-2016.1.16. PMC 6142460. PMID 27913457.
Collin M, Bigley V (May 2018). "Human dendritic cell subsets: an update". Immunology. 154 (1): 3–20. doi:10.1111/imm.12888. PMC 5904714. PMID 29313948.

pharmatimes.com

McKee, Selina (2017-09-05). "FDA holds trials of Cellectis' cell therapy after patient death". www.pharmatimes.com. Retrieved 2017-10-08.

semanticscholar.org

api.semanticscholar.org

Slater DN (November 2005). "The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants". The British Journal of Dermatology. 153 (5): 874–80. doi:10.1111/j.1365-2133.2005.06905.x. PMID 16225594. S2CID 23625855.
Kim MJ, Nasr A, Kabir B, de Nanassy J, Tang K, Menzies-Toman D, Johnston D, El Demellawy D (October 2017). "Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review". Journal of Pediatric Hematology/Oncology. 39 (7): 528–537. doi:10.1097/MPH.0000000000000964. PMID 28906324. S2CID 11799428.
Pemmaraju N (December 2017). "Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond". Current Hematologic Malignancy Reports. 12 (6): 510–512. doi:10.1007/s11899-017-0425-7. PMID 29064022. S2CID 207330989.
Wang S, Wang X, Liu M, Bai O (April 2018). "Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents". Annals of Hematology. 97 (4): 563–572. doi:10.1007/s00277-018-3259-z. PMID 29455234. S2CID 3627886.
Sumarriva Lezama L, Chisholm KM, Carneal E, Nagy A, Cascio MJ, Yan J, Chang CC, Cherry A, George TI, Ohgami RS (June 2018). "An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality". Histopathology. 73 (5): 767–776. doi:10.1111/his.13668. PMID 29884995. S2CID 47003308.
Suma S, Sakata-Yanagimoto M, Nguyen TB, Hattori K, Sato T, Noguchi M, Nannya Y, Ogawa S, Watanabe R, Fujimoto M, Nakamura N, Kusakabe M, Nishikii H, Kato T, Chiba S (April 2018). "Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis". International Journal of Hematology. 108 (4): 447–451. doi:10.1007/s12185-018-2461-z. PMID 29705980. S2CID 13993911.

worldcat.org

Tandon, a.; Zhang, y.; Sokol, l. (2019). "Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm". Drugs of Today. 55 (12). Portico: 735–742. doi:10.1358/dot.2019.55.12.3058917. ISSN 1699-4019. PMID 31942876.